Regarding the role of inflammation on the production of Shh + MPs in the setting of PAD, it should be said that this may certainly be a possible mechanism, based on the notion that pathologies associated with systemic or local inflammation are commonly associated with MP production [15] and that, in PAD, the production of Shh + MPs might be finalized to limit inflammation [17]. This evidence concerns the gene SHH and peripheral arterial disease.